Reduction in the therapeutic intensity of abortive migraine drug use during ACE inhibition therapy--a pilot study.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D057912:Angiotensin II Type 2 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D004363:Drug Utilization; D004878:Ergotamine / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy*; D010865:Pilot Projects; D012189:Retrospective Studies; D017366:Serotonin Receptor Agonists / Q000008:administration & dosage / Q000627:therapeutic use*
D057912:Angiotensin II Type 2 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D017366:Serotonin Receptor Agonists; D004878:Ergotamine